Trevi Therapeutics
TRVI
#4528
Rank
A$3.56 B
Marketcap
A$25.11
Share price
2.07%
Change (1 day)
109.58%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2026 (TTM): -A$70.6 Million

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$62.93 Million, an increase over its 2024 earnings that were of -A$68.65 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$70.6 Million12.19%
2025 -A$62.93 Million-8.34%
2024 -A$68.65 Million67%
2023 -A$41.11 Million2.43%
2022 -A$40.14 Million-14.45%
2021 -A$46.92 Million1.36%
2020 -A$46.29 Million23.64%
2019 -A$37.44 Million27.54%
2018 -A$29.35 Million